July 14, 2017 02:40 PM EDTUpdated July 17, 10:22 AM
People

Pas­cal So­ri­ot is stay­ing at As­traZeneca af­ter all, con­firm­ing up­com­ing pre­sen­ta­tion - re­ports

John Carroll

Editor & Founder

As­traZeneca has stayed mum for two long days filled with an in­tense round of ru­mors and spec­u­la­tion over the fu­ture of their CEO, Pas­cal So­ri­ot …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times